Angel E. Alsina M.D., FACS, FAASLD
Trustworthy resource for
extensive medical, surgical and medico-legal expertise,
professional judgement, and highest ethical standards in liver medicine and related inquiries
24 years of liver transplant experience at a tertiary care, 1,010 bed teaching hospital. Trained at the Harvard Department of Surgery, New England Deaconess Hospital in Hepato-Biliary Surgery and Liver Transplantation.
American Board of Surgery certified. Fellow of the American Association for the Study of Liver Diseases and Fellow of the American College of Surgeons. Collaborative Professor at the University of South Florida, Morsani College of Medicine.
Broad knowledge in various fields: general surgery, liver surgery, transplantation, hepatology (hepatitis C, drug-induced injuries and liver disorders), and hepato-oncology (liver cancer). Directed liver transplantation and liver cancer programs for a total of 20 years. Proven track record: his liver transplant program performed at 96th percentile in long term outcomes, nationally. Evaluated over 5,000 new liver cancer patients.
Principal investigator and researcher in 27 pivotal trials of liver transplantation, acute liver failure, fatty liver, hepatitits C, and liver cancer. Published in topics of acute liver failure, liver cancer, liver transplantation, cirrhosis and portal hypertension, ethnic and ethical aspects of transplantation, and liver oncology. Expert CME teacher nationally, advisor, research mentor.
Experienced medico-legal expert witness and consultant in surgical complications, hepatology, liver transplantation, liver oncology (cancer), bile duct injuries, drug-induced liver injuries, Correctional Medicine and Hepatitis C treatment in inmates, life expectancy in liver disease, and disability for transplant surgeons.
CON GUSTO LE ATIENDO
To apply my decades of extensive medical field experience,
up-to-date medical expertise and ethical integrity,
to address a wide range of liver medicine-related cases and inquiries
towards viable resolutions and most favorable outcomes
for individuals, businesses, industry and the medical field.